Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.
![Tengion logo](https://files.capedge.com/S-1A/0000950159-13-000195/tengion.jpg)
Company profile
Ticker
TNGNQ
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
200214813
TNGNQ stock data
Latest filings (excl ownership)
424B3
Prospectus supplement
29 Dec 14
424B3
Prospectus supplement
29 Dec 14
424B3
Prospectus supplement
29 Dec 14
8-K
Bankruptcy or Receivership
29 Dec 14
424B3
Prospectus supplement
5 Dec 14
424B3
Prospectus supplement
5 Dec 14
424B3
Prospectus supplement
5 Dec 14
8-K
Entry into a Material Definitive Agreement
5 Dec 14
424B3
Prospectus supplement
3 Dec 14
424B3
Prospectus supplement
3 Dec 14
Latest ownership filings
SC 13G/A
Hudson Bay Capital Management LP
11 Feb 21
SC 13G/A
Tengion Inc
30 Jan 17
SC 13G/A
Tengion Inc
16 Feb 16
SC 13G/A
Tengion Inc
12 Feb 16
SC 13G
Tengion Inc
2 Oct 15
SC 13G/A
Tengion Inc
17 Feb 15
SC 13G/A
Tengion Inc
17 Feb 15
SC 13G/A
Tengion Inc
17 Feb 15
SC 13G/A
Tengion Inc
13 Feb 15
SC 13G/A
Tengion Inc
13 Feb 15
Institutional ownership, Q1 2021
10.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 3.86 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Hudson Bay Capital Management | 3.86 mm | $0.00 |